 | Up a level |
2019
Smith, Matthew, Parker, Chris, Saad, Fred, Miller, Kurt, Tombal, Bertrand, Ng, Quan Sing, Boegemann, Martin, Matveev, Vsevolod, Piulats, Josep Maria, Zucca, Luis Eduardo, Karyakin, Oleg, Kimura, Go 
ORCID: 0000-0003-0088-9324, Matsubara, Nobuaki, Nahas, William Carlos, Nole, Franco, Rosenbaum, Eli, Heidenreich, Axel, Kakehi, Yoshiyuki, Zhang, Amity, Krissel, Heiko, Teufel, Michael, Shen, Junwu, Wagner, Volker and Higano, Celestia
(2019).
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol., 20 (3).
S. 408 - 420.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488